7EB-26952-23194
3 vaccinations
4 coded responses
28 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 731 / OK
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-22
Registered in v-safe
-
2021-02-22
Dose 1 — Pfizer-BioNTech
-
2021-02-22
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-23
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Fair · Site: PainFree text: Loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-28
- 2021-03-03
- 2021-03-08
-
2021-03-15
Dose 2 — Pfizer-BioNTech
- 2021-03-17
- 2021-03-19
- 2021-03-20
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-26
-
2021-06-14
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-13
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-09-13
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-15
-
2021-10-01
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-12-31
- 2022-04-01
-
2022-10-03
Survey response — 12 months, dose 3MedDRA: Mastitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Mastitis.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-04
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-22 | Pfizer-BioNTech | |
| 2 | 2021-03-15 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-13 | Unsuccessful | |
| 2022-10-03 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Loss of appetite
Release 9 — 3 months, dose 2
Symptoms: Pregnancy
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 12 — 12 months, dose 3
Symptoms: Mastitis.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Mastitis | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release